Metabolic Reprogramming: A Cancer Hallmark Even Warburg Did Not Anticipate

Ward, Patrick S., Thompson, Craig B.·2012·Cancer Cell
DOI 10.1016/j.ccr.2012.02.014

Cited by (1,011)

Items 1,001–1,011 of 1,011

  1. Discovery of human cell selective effector molecules using single cell multiplexed activity metabolomics
    Earl, David C., Ferrell, P. Brent, Leelatian, Nalin, Froese, Jordan T., Reisman, Benjamin J., Irish, Jonathan M., Bachmann, Brian O. · 2018 · Nature Communications
  2. Metabolic alterations accompanying oncogene-induced senescence
    Aird, Katherine M, Zhang, Rugang · 2014 · Molecular & Cellular Oncology
  3. Imaging of glucose metabolism by 13C-MRI distinguishes pancreatic cancer subtypes in mice
    Kishimoto, Shun, Brender, Jeffrey R, Crooks, Daniel R, Matsumoto, Shingo, Seki, Tomohiro, Oshima, Nobu, Merkle, Hellmut, Lin, Penghui, Reed, Galen, Chen, Albert P et al. · 2019 · eLife
  4. Exploiting the Achilles' heel of cancer: disrupting glutamine metabolism for effective cancer treatment
    Fan, Yuxin, Xue, Han, Li, Zhimin, Huo, Mingge, Gao, Hongxia, Guan, Xingang · 2024 · Frontiers in Pharmacology
  5. Molecular imaging of the tumor microenvironment reveals the relationship between tumor oxygenation, glucose uptake, and glycolysis in pancreatic ductal adenocarcinoma
    Yamamoto, Kazutoshi, Brender, Jeffrey R., Seki, Tomohiro, Kishimoto, Shun, Oshima, Nobu, Choudhuri, Rajani, Adler, Stephen S., Jagoda, Elaine M., Saito, Keita, Devasahayam, Nallathamby et al. · 2020 · Cancer Research
  6. Conditional knockout of hypoxia-inducible factor 1-alpha in tumor-infiltrating neutrophils protects against pancreatic ductal adenocarcinoma
    Sieow, Je Lin, Penny, Hweixian Leong, Gun, Sin Yee, Tan, Ling Qiao, Duan, Kaibo, Yeong, Joe Poh Sheng, Pang, Angela, Lim, Diana, Toh, Han Chong, Lim, Tony Kiat Hon et al. · 2023 · International Journal of Molecular Sciences
  7. Epigenome modifiers and metabolic rewiring: New frontiers in therapeutics
    Ferrari, Alessandra, Longo, Raffaella, Silva, Rui, Mitro, Nico, Caruso, Donatella, De Fabiani, Emma, Crestani, Maurizio · 2019 · Pharmacology & Therapeutics
  8. NRF3 activates mTORC1 arginine-dependently for cancer cell viability
    Hirose, Shuuhei, Waku, Tsuyoshi, Tani, Misato, Masuda, Haruka, Endo, Keiko, Ashitani, Sanae, Aketa, Iori, Kitano, Hina, Nakada, Sota, Wada, Ayaka et al. · 2023 · iScience
  9. p53-independent effects of Set7/9 lysine methyltransferase on metabolism of non-small cell lung cancer cells
    Daks, Alexandra, Shuvalov, Oleg, Fedorova, Olga, Petukhov, Alexey, Lezina, Larissa, Zharova, Arsenia, Baidyuk, Ekaterina, Khudiakov, Alexander, Barlev, Nickolai A. · 2021 · Frontiers in Oncology
  10. Mangiferin targets PFKFB3 to inhibit glioblastoma progression by suppressing glycolysis and PI3K/AKT/mTOR signaling
    Xia, Jiajie, Li, Xiao, Yao, Jun, Song, Dagang, Gu, Zhiwei, Zheng, Gang, Tu, Chuanjian · 2025 · Brain Research Bulletin
  11. Energy stress and adaptation strategy of tumor cells in different microenvironments: from primary tumors to distant metastases
    Xu, Mingzhe, Fei, Junjie, Xiao, Zhi-Xiong, Yi, Yong · 2026 · Acta Biochimica et Biophysica Sinica